Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-25-007387
Filing Date
2025-01-21
Accepted
2025-01-21 17:16:33
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B3 scilex_424b3_1.21.2025_s.htm 424B3 107028
2 GRAPHIC img225932534_0.jpg GRAPHIC 43426
3 GRAPHIC img225932534_1.jpg GRAPHIC 15252
4 GRAPHIC img225932534_2.jpg GRAPHIC 19678
5 GRAPHIC img225932534_3.jpg GRAPHIC 35969
6 GRAPHIC img225932534_4.jpg GRAPHIC 43426
7 GRAPHIC img225932534_5.jpg GRAPHIC 15252
8 GRAPHIC img225932534_6.jpg GRAPHIC 19678
9 GRAPHIC img225932534_7.jpg GRAPHIC 35969
  Complete submission text file 0000950170-25-007387.txt   424250
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-268603 | Film No.: 25543315
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)